CervoMed (CRVO) - 2023 Q2 - Quarterly Report

DIFFUSION PHARMACEUTICALS INC. The following table summarizes the activity related to all stock option grants for the six months ended June 30, 2023: There were no options granted during the six months ended June 30, 2023. The total fair value of options vested during the three months ended June 30, 2023 and 2022 was $0.1 million and$0.3 million, respectively. The total fair value of options vested during the six months ended June 30, 2023 and 2022 was $0.2 million and$0.5 million, respectively. No option ...